Business · 08/06/2010
FDA Announces Public Workshop on Medical Products for Kidney Transplant Recipients
The Food and Drug Administration (FDA) is hosting a public workshop to discuss issues related to the development of medical products for the prophylaxis and/or treatment of acute antibody-mediated rejection in kidney transplant recipients.